These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33660516)

  • 1. Novel Acoustic Biomarker of Quality of Life in Left Ventricular Assist Device Recipients.
    Mainsah BO; Patel PA; Chen XJ; Olsen C; Collins LM; Karra R
    J Am Heart Assoc; 2021 Mar; 10(6):e018588. PubMed ID: 33660516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Sound Analysis in Individuals Supported With Left Ventricular Assist Devices.
    Chen XJ; LaPorte ET; Olsen C; Collins LM; Patel P; Karra R; Mainsah BO
    IEEE Trans Biomed Eng; 2021 Oct; 68(10):3009-3018. PubMed ID: 33606625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First experiences with HeartMate 3 follow-up and adverse events.
    Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic Characterization of Axial Flow Left Ventricular Assist Device Operation In Vitro and In Vivo.
    Yost GL; Royston TJ; Bhat G; Tatooles AJ
    ASAIO J; 2016; 62(1):46-55. PubMed ID: 26536535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of aortic valve regurgitation after continuous-flow left ventricular assist device implantation using artificial intelligence trained on acoustic spectra.
    Misumi Y; Miyagawa S; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Maruyama Y; Ueno T; Toda K; Asanoi H; Sawa Y
    J Artif Organs; 2021 Jun; 24(2):164-172. PubMed ID: 33537860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
    Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
    J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal comparison of health-related quality of life in rural and urban recipients of left ventricular assist devices.
    Alonso WW; Faulkner KM; Pozehl BJ; Hupcey JE; Kitko LA; Lee CS
    Res Nurs Health; 2020 Aug; 43(4):396-406. PubMed ID: 32627852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
    Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
    Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock.
    Schurr JW; Ambrosi L; Fitzgerald J; Bermudez C; Genuardi MV; Brahier M; Elliot T; McGowan K; Zaaqoq A; Laskar S; Pope SM; Givertz MM; Mallidi H; Sylvester KW; Seifert FC; McLarty AJ
    Artif Organs; 2024 Aug; 48(8):921-931. PubMed ID: 38459758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
    Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Cardiac Surgical Procedures in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation.
    Eisenberger J; Somer S; Nachum E; Ram E; Lavee J; Sternik L; Morgan J
    Isr Med Assoc J; 2024 May; 26(5):278-282. PubMed ID: 38736341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.